AstraZeneca’s Antibody Cocktail Fails to Prevent Covid: Study

AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push.

Similar Articles

Comments

spot_img

Most Popular

You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign